Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2-positive Early Breast Cancer × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Pancreatic Neoplasms 32 Carcinoma, Non-Small-Cell Lung 32 Triple Negative Breast Neoplasms 23 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 11 Lung Neoplasms 11 Melanoma 6 Breast Neoplasms, Male 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Cholangiocarcinoma 5 Inflammatory Breast Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Transitional Cell 4 Brenner Tumor 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Pleural Effusion, Malignant 3 Pancreatic Adenocarcinoma 3 Neoplasms 3 Nasopharyngeal Carcinoma 3 Endometrial Neoplasms 3 Advanced Pancreatic Cancer 3 Adenocarcinoma 3 Uveal Melanoma 2 Thymoma 2

Interventions

pyrotinib 1 pertuzumab 1 Trastuzumab 1 Taxes 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340398 2026-01-21

TAYLOR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting

HER2-positive Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡